Viruses | Top Cited Papers in 2020

1. “Virology, Epidemiology, Pathogenesis, and Control of COVID-19”
by Yuefei Jin et al.
Viruses 2020, 12(4), 372; https://doi.org/10.3390/v12040372
Available online: https://www.mdpi.com/1999-4915/12/4/372
Cited by 751 | Viewed by 75036

2. “Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies”
by Syed Faraz Ahmed et al.
Viruses 2020, 12(3), 254; https://doi.org/10.3390/v12030254
Available online: https://www.mdpi.com/1999-4915/12/3/254
Cited by 687 | Viewed by 59383

3. “Return of the Coronavirus: 2019-nCoV”
by Lisa E. Gralinski et al.
Viruses 2020, 12(2), 135; https://doi.org/10.3390/v12020135
Available online: https://www.mdpi.com/1999-4915/12/2/135
Cited by 684 | Viewed by 91557

4. “Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections”
by David A. Schwartz et al.
Viruses 2020, 12(2), 194; https://doi.org/10.3390/v12020194
Available online: https://www.mdpi.com/1999-4915/12/2/194
Cited by 545 | Viewed by 32959

5. “Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV”
by Jiabao Xu et al.
Viruses 2020, 12(2), 244; https://doi.org/10.3390/v12020244
Available online: http://www.mdpi.com/1999-4915/12/2/244
Cited by 399 | Viewed by 37502

6. “Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays”
by Katharine H. D. Crawford et al.
Viruses 2020, 12(5), 513; https://doi.org/10.3390/v12050513
Available online: http://www.mdpi.com/1999-4915/12/5/513
Cited by 341 | Viewed by 13192

7. “Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2”
by Nadin Younes et al.
Viruses 2020, 12(6), 582; https://doi.org/10.3390/v12060582
Available online: http://www.mdpi.com/1999-4915/12/6/582
Cited by 202 | Viewed by 13646

8. “Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins”
by Suhas Srinivasan et al.
Viruses 2020, 12(4), 360; https://doi.org/10.3390/v12040360
Available online: http://www.mdpi.com/1999-4915/12/4/360
Cited by 134 | Viewed by 16756

9. “The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner”
by Mizuki Yamamoto et al.
Viruses 2020, 12(6), 629; https://doi.org/10.3390/v12060629
Available online: http://www.mdpi.com/1999-4915/12/6/629
Cited by 133 | Viewed by 4236

10. “SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions”
by Mohammed Uddin et al.
Viruses 2020, 12(5), 526; https://doi.org/10.3390/v12050526
Available online: http://www.mdpi.com/1999-4915/12/5/526
Cited by 125 | Viewed by 14756